Top Eminent Healthcare Group (HKSE:06877) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Top Eminent Healthcare Group Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Top Eminent Healthcare Group Valuation Rank Related Terms

Top Eminent Healthcare Group Business Description

Address 88 Queensway, Suite 810, Level 8, One Pacific Place, Hong Kong, HKG
Top Eminent Healthcare Group Ltd formerly CLSA Premium Ltd operates in the financial services sector. It provides leveraged forex and other trading, cash dealing, sales of healthcare products, and other services.. The operating segments of the group are the Margin dealing segment. Unallocated segment, Healthcare products segment, The margin dealing segment is engaged in the provision of leveraged foreign exchange, commodity, and index trading services in Australia, Hong Kong, and New Zealand. The healthcare products segment engages in the sales of healthcare products. It has a business presence in Hong Kong, Australia, New Zealand, and Other countries.